Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Sales, net	$ 19,495	$ 17,063	$ 62,374	$ 51,054
Cost of sales	7,526	6,856	24,531	20,273
Gross profit	11,969	10,207	37,843	30,781
Operating expenses:
Sales and marketing	6,035	5,868	19,918	22,126
Research and development	1,241	1,224	3,799	3,547
General and administrative	5,840	6,180	19,557	22,292
Total operating expenses	13,116	13,272	43,274	47,965
Operating loss	(1,147)	(3,065)	(5,431)	(17,184)
Nonoperating income (expenses):
Other income, net - Employee Retention Tax Credit	0	2,085	0	2,085
Interest income (expense), net	188	(5)	379	(23)
Net loss	$ (959)	$ (985)	$ (5,052)	$ (15,122)
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.07)	$ (0.22)
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.07)	$ (0.22)
Basic weighted average common shares outstanding (in shares)	75,050	68,345	74,938	68,331
Diluted weighted average common shares outstanding (in shares)	75,050	68,345	74,938	68,331